Global Branded Generics Market

Nutritional feed additives various types of products used in animal nutrition to improve the nutritional content and quality of feed, or to improve the health and performance of animals. They help improve the nutritional content and quality of feed, resulting in higher productivity and disease prevention. The main additive types of nutritional feed additives are antibiotics, vitamins, antioxidants, amino acids, enzymes, mycotoxin detoxifiers, prebiotics, probiotics, flavours and sweeteners, pigments, binders, and minerals. Antibiotics are medications that aid in the treatment of bacterial illnesses. They accomplish this by either killing the bacteria or preventing them from replicating or reproducing. The nutritional feed additives are available in various forms, such as dry, liquid, and other forms that are used on ruminants, poultry, swine, and aquatic livestock. The additives are distributed through direct, indirect channels; hypermarkets and supermarkets; specialty stores, and online retail channels. The nutritional feed additives research report is one of a series of new reports from The Business Research Company that provides nutritional feed additives statistics, including nutritional feed additives industry global market size, regional shares, competitors with nutritional feed additives share, detailed nutritional feed additives segments, market trends and opportunities, and any further data you may need to thrive in the nutritional feed additives industry. This nutritional feed additives research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nutritional feed additives market size will grow from $3.89 billion in 2022 to $4.19 billion in 2023 at a compound annual growth rate (CAGR) of 7.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global nutritional feed additives market size is expected to grow to $5.41 billion in 2027 at a CAGR of 6.6%. The rise in consumption of meat products is one of the driving factors for the nutrition feed additives market. Due to high meat consumption, the concern for high-quality meat is also increasing. Thus, to deliver high-quality meat, add-on nutrition feed additives are fed to the animals so that they have good digestion to build on more muscle and weight. This increases the yield and productivity and, hence, the demand for nutritional feed additives. Currently, meat and poultry consumption in the US is more than 100 billion pounds every year. The stringent regulations act as one of the major restraining factors for the nutrition feed additives market. There are many mandatory documents, required to be approved before approving the nutritional feed, which delays the approval process. Therefore, the product launch and expansion of companies in new regional markets will be delayed. For instance, China's AQSIQ (Administration for Quality Supervision and Inspection and Quarantine) issued 2 reports for the nutrition feed additive companies to get their products registered and approved by the concerned Chinese authorities before selling them in the Chinese market. The report also made it compulsory for all the exporters to have a licence to sell their nutrition feed additive products in the Chinese market, which delays the nutritional feed additives from reaching the stores. Feed additives manufacturers are investing in the R&D of organic feed additives as there is a growing demand for organic and natural feed products in the nutritional feed additives market. When compared to synthetic nutrition feed additives, organic feed additives have fewer side effects and also improve yield. Therefore, poultry farmers are switching to herbal nutrition feed additives. For instance, Agpulse Organics has come up with its herbal animal feed additive 'Govahnika-Biosheera', which is fed to cattle to increase milk productivity while maintaining the health of cattle and quality of milk. In September 2020, Adisseo acquired Framelco G for an undisclosed amount. With this acquisition, the company will enhance the growth of specialties to become the world leader in the field of specialty feed ingredients in animal nutrition. Framelco G is a family-owned multinational company that develops and manufactures feed additives and drinking water solutions for livestock production. Major players in the nutritional feed additives market are BASF SE, Cargill, Archer Daniels Midland Company, Evonik Industries AG, Nutreco N.V., Kemin Industries Inc., Adisseo, Alltech, Phibro Animal Health Corporation, and DowDuPont. North America was the largest region in the nutritional feed additives market in 2022. Asia-Pacific was the second-largest region in the global nutritional feed additives market. The regions covered in the global nutritional feed additives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nutritional feed additives market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The nutritional feed additives market consists of sales of digestibility enhancers, coccidiostats and histomonostats, antimicrobials, and growth hormones. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nutritional feed additives market is segmented - 1) By Distribution Channel: Direct, Indirect, Hypermarket/Supermarket, Specialty Stores, Online Retail 2) By Livestock: Ruminants, Poultry, Swine, Aquatic 3) By Additive Type: Antibiotics, Vitamins, Antioxidants, Amino Acids, Enzymes, Mycotoxin Detoxifiers, Prebiotics, Probiotics, Flavors And Sweeteners, Pigments, Binders, Minerals 4) By Form: Dry, Liquid, Other Forms

A pharmacy is where one can get prescription medications. It may be located inside a grocery shop, drugstore, chemist, or other establishment. Drug store refers to a location whose major activity is the selling of pharmaceuticals, medicines, and pharmaceutical preparations. Drug stores have a regular prescription department and hire a registered pharmacist on-site at all times. The main drug types of pharmacies and drug stores are prescription drugs and over-the-counter drugs. Prescription drugs refer to a drug that can be obtained only with a physician's prescription. The various types involved are community pharmacy, hospital pharmacy, clinical pharmacy, industrial pharmacy, compounding pharmacy, consulting pharmacy, ambulatory care pharmacy, regulatory pharmacy, and homecare pharmacy. The different product types included are skincare, cold and flu, dental, weight loss, vitamins, and other product types. The pharmacies and drug stores market research report is one of a series of new reports from The Business Research Company that provides pharmacies and drug stores market statistics, including pharmacies and drug stores industry global market size, regional shares, competitors with a pharmacies and drug stores market share, detailed pharmacies and drug stores market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacies and drug stores industry. This pharmacies and drug stores market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pharmacies and drug stores market size will grow from $1,126.63 billion in 2022 to $1,205.81 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global pharmacies and drug stores market size is expected to grow to $1,513.65 billion in 2027 at a CAGR of 5.8%. The growing ageing population and increasing health consciousness among the global populace are likely to drive the pharmacy and drug store market. The geriatric population is more vulnerable to acquiring several diseases that increase their dependence on pharmacies and drug stores, thus indirectly affecting the market. According to the Global Health and Aging report, the number of people aged 65 or older is projected to grow to nearly 1.5 billion in 2050, with most of the increase in developing countries. Certain health conditions are expected to be a challenge to our health care system with the increasing ageing population. These conditions include cancer, dementia, an increase in the number of falls, obesity, and diabetes. Due to the increasing aging population, the number of cases is expected to increase, thus providing a growing customer base for pharmacies and drug stores. Rapidly increasing cost pressures from regulatory agencies and payers will restrain the pharmacies and drug stores market. Government budgetary pressures are leading to lower pharmacy compensation for most countries with public health care. The consolidation of pharmacy benefit management firms in the U.S. has worked similarly, driving lower costs and margins, and shifting prescription volumes to the delivery of direct or mail orders. Governments would be the largest healthcare payers in virtually every country. This, in turn, creates increased pressure on taxpayers and government spending, with consequent pharmaceutical effects. These factors are expected to have a negative impact on the pharmacies and drug stores market as they increase cost pressures from regulatory agencies and affect the market’s growth. Working long hours and drive-through locations are the major factors contributing to increasing the pharmacy and drugstore market growth. As competition has increased from mass merchandisers and supermarkets, as well as from direct mail prescription services, drug stores have been adding value in the form of 24-hour operations and drive-through pharmacies. The US Pharmacy Study measures customer satisfaction with their pharmacy experience across major chain drug stores, mass merchandisers, supermarkets, and mail-order pharmacies. The study shows that retail pharmacy businesses continue to shine when it comes to engaging patient-centric services that drive satisfaction. These convenience factors anticipate the growth of pharmacies and the drugstore market. In January 2021, AmerisourceBergen Corporation, a US-based drug wholesale company, acquired Walgreens Boots Alliance, Inc. for the amount of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock. Acquiring Alliance Healthcare will provide even stronger support for pharmacies and pharmacists across the world and integrate solutions for pharmaceutical manufacturers. Walgreens Boots Alliance, Inc. is a US-based holding company that owns the retail pharmacy chains and manufactures pharmaceuticals and distribution companies. Major players in the pharmacies and drug stores market are Walgreens Boots (WBA), CVS Health (CVS), Rite Aid (RAD), MedPlus, Rexall, Shoppers Drug Mart, Grupo Casa Saba, China Nepstar, AS Watson, and Matsumoto Kiyoshi. Asia-Pacific was the largest region in the pharmacies and drug stores market in 2022. North America was the second-largest region in the global pharmacies and drug stores market. The regions covered in the global pharmacies and drug stores market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the pharmacies and drug stores market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pharmacies and drug stores market include revenues earned by entities by branded prescription drugs, generic drugs, non-prescription medicines, personal health supplies, and dietary supplements, cosmetics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmacies and drug stores market is segmented - 1) By Drug Type: Prescription Drugs, OTC drugs 2) By Type: Community Pharmacy, Hospital Pharmacy, Clinical Pharmacy, Industrial Pharmacy, Compounding Pharmacy, Consulting Pharmacy, Ambulatory Care Pharmacy, Regulatory Pharmacy, Home Care Pharmacy 3) By Product Type: Skin Care, Cold and Flu, Dental, Weight Loss, Vitamins, Other Product Types

Functional foods are highly nutritious foods that are associated with many health benefits. The benefits include prevention against nutrition deficiencies, protection against diseases, improved cholesterol levels, lower blood pressure, and promotion of proper growth & development. The main product types are bakery & cereals, dairy products, meat, fish & eggs, soy products, fats & oils, and other product types. A dairy product is milk and any of the foods made from milk, including butter, cheese, ice cream, yogurt, and condensed and dried milk. The ingredients used for functional foods are carotenoids, dietary fibers, fatty acids, minerals, prebiotics, probiotics, vitamins, and other product types. The various applications of these food products are sports nutrition, weight management, immunity, digestive health, clinical nutrition, cardio health, and other product types. The functional food research report is one of a series of new reports from The Business Research Company that provides functional food statistics, including functional food industry global market size, regional shares, competitors with functional food share, detailed functional food segments, market trends and opportunities, and any further data you may need to thrive in the functional food industry. This functional food research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global functional foods market size will grow from $203.64 billion in 2022 to $229.7 billion in 2023 at a compound annual growth rate (CAGR) of 12.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global functional foods market size is expected to grow from $354.96 billion in 2027 at a CAGR of 11.5%. The increasing number of diseases is shifting consumers' focus to healthy eating, which in turn is projected to boost the demand for functional foods. Functional food provides the human body with healthy nutrition, vitamins and minerals, and reduces the risk of diseases. According to the Centre for Disease Control and Prevention, heart disease is a leading cause of death in the USA, and about 6,47,000 Americans die from heart disease every year, which is one out of every four deaths. Therefore, the increasing number of cardiovascular and other diseases across the globe is anticipated to generate higher demand for a healthy diet, which in turn, is likely to propel the revenues of the functional food market over the forecast period. The higher price of functional food products attributed to the inclusion of healthier or natural ingredients is limiting the growth of the functional food market. Functional foods are sold at higher prices and hold larger profit margins than conventional foods. Functional foods are priced 30 to 500% higher than comparable conventional foods. Thus, the higher prices of functional food are to act as a major restraint for the growth of the functional food market over the forthcoming years. Key players dealing in the functional food market are increasingly focusing on new product developments and company expansion to meet the rising demand from consumers. For instance, in January 2022, Fonterra Co-operative Group Limited, New-Zealand-based dairy company, Tillamook Country Creamery Association (TCAA), and Three Mile Canyon Farm, introduced Pro-Optima TM, A-grade functional whey protein concentrate. Pro-Optima TM can be used in cultured products such as yogurt, to enhance the textures to deliver multi-functional benefits. In July 2021, Kerry Group, an Ireland-based food company acquired Biosearch Life for a deal of $ 150 million. Through this acquisition, Kerry Group aims to expand its product portfolio in health ingredients such as probiotics and omega 3s. Biosearch Life is a Spain-based biotechnology company. Major players in the functional food market are, Unilever, BNL Food Group, Dean Foods, The Coca-Cola Company, Arla Foods, Abbott Laboratories, PepsiCo Inc., Kraft Foods Inc., and Nestle. Asia-Pacific was the largest region in the functional food market in 2022. Western Europe was the second-largest region in the global functional foods market. The regions covered in the global functional foods market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the functional food market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The functional food market consists of sales of fatty acids, carotenoids, prebiotics & probiotics, vitamins, dietary fibers, minerals, and other functional foods. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global functional foods market is segmented - 1) By Product Type: Bakery & Cereals, Dairy Products, Meat, Fish & Eggs, Soy Products, Fats & Oils, Other Product Types 2) By Ingredients: Carotenoids, Dietary Fibers, Fatty Acids, Minerals, Prebiotics & Probiotics, Vitamins, Other Ingerdients 3) By Application: Sports Nutrition, Weight Management, Immunity, Digestive Health, Clinical Nutrition, Cardio Health, Other Applications

Vitamins and mineral supplements refer to the micronutrients that the body needs to perform a variety of typical tasks. These micronutrients must, however, be obtained from the food we eat because they are not generated by our bodies. Organic compounds known as vitamins are often classified as either fat-soluble or water-soluble. The main types of vitamin and mineral supplements are multivitamins, single vitamins, multi-mineral supplements, and single minerals. A multivitamin is a dietary supplement that contains all or most of the vitamins that the body does not produce. The various distribution channels involved are pharmacies and drug stores, supermarkets and hypermarkets, and online channels that are used for energy and weight management, general health, bone, and joint health, gastrointestinal health, immunity, cardiac health, diabetes, anti-cancer, and others. The vitamins and mineral supplements market research report are one of a series of new reports from The Business Research Company that provides vitamins and mineral supplements market statistics, including vitamins and mineral supplements industry global market size, regional shares, competitors with vitamins and mineral supplements market share, detailed vitamins and mineral supplements market segments, market trends and opportunities, and any further data you may need to thrive in the vitamins and mineral supplements industry. This vitamins and mineral supplements market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global vitamin and minerals market grew from $21.37 billion in 2022 to $22.65 billion in 2023 at a compound annual growth rate (CAGR) of 6.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The vitamin and minerals market is expected to grow from $26.27 billion in 2027 at a CAGR of 3.8%. The growing use of dietary supplements in the modern lifestyle is a key factor driving the growth of the vitamins and mineral supplement market. Nutrition plays an important role in maintaining immune system balance, and supplementation with the micronutrients such as vitamins C and D, zinc, and omega fatty acids within recommended upper safety limits is a safe, effective and low-cost strategy to help support optimal immune function in patients fighting COVID-19 and other respiratory tract diseases. In the case of COVID-19 patients, a variety of high-protein and fibrous foods, including cookies, bread, and rolls, have been developed by the Indian Research Institute. For example, to improve children's immunity, dietary supplement company Avida Health has launched a chocolate ball functional food in Singapore. A nutritional focus on the immune system could help minimize the impact of the current COVID-19 pandemic and other infections. Therefore, the implementation of dietary supplements in the lifestyle is expected to drive the growth of the vitamins and mineral supplement market. The disruptions in supply chains for the production of supplements are a key factor hampering the growth of the vitamins and mineral supplement market. COVID-19 outbreak has led to restrictive containment measures involving social distancing and remote working, and the closure of industries and other commercial activities. The entire supply chain from production to international trade has been impacted. The economic crisis due to COVID-19 is also impacting dietary supplements by disrupting distribution networks. The economically important supplements have a fragile supply chain and failure in any stage of the supply chain from farms to dealers, haulers, and distributors to manufacturers can disrupt the entire chain. International Food Policy Research Institute (IFPRI) has gathered evidence of major disruptions to livestock production in China, and vegetables and fruits in Ethiopia, whereas Indian news reported a full-blown collapse in the production of dairy products, which is especially worrying the countries where milk and milk products remain key sources of primary nutrients for young children. Therefore, disruptions in supply chains for nutrient-rich foods are expected to hinder the growth of the vitamins and mineral supplement market. The consumer preference moving toward organic supplements is a key trend in the vitamins and mineral supplement market. There was a suggested transition towards vegan & organic food in 2020, and this trend will shortly become a lifestyle for many people as COVID-19 is taking the world by storm. As a lot of people globally believe that the COVID crisis is associated with the consumption of animal meat, people will become more cautious of the food they consume and this can result in a significant rise in the demand for organic and vegan food products. Many small and medium enterprises have started to promote plant-based goods and diets in the product space. The coronavirus pandemic is accelerating the trend for organic food supplements. In April 2020, American Regent Inc., a US manufacturer of pharmaceuticals for human and veterinary use with manufacturing sites in New York and Ohio, acquired Daiichi Sankyo for an undisclosed amount. This acquisition increases American Regent’s production and provides the opportunity to explore other products to manufacture, allowing the company to continue to find innovative ways of responding to customer needs. Daiichi Sankyo is a pharmaceutical company with its corporate origins in Japan. Major players in the vitamins and minerals supplements market are Salus Haus, Pfizer, Daiichi Sankyo, AMWAY, Eisai, Sanofi, GNC, CSPC Pharmaceutical Group, DSM, Otsuka Holdings Co. Ltd., Puritan’s Pride, Pharmavite, Jamieson, Webber Naturals, Hainan Yangshengtang, Nature’s Bounty, CCMP Capital, Pharmavite, Suntory Holdings Ltd., Glanbia PLC., Glaxosmithkline PLC., Abbott Laboratories, Bayer AG, Puritan's Pride, General Nutrition CentersInc., Webber Naturals, CSPC Pharmaceutical Group, and Hainan Yangshengtang. North America was the largest region in the vitamins and minerals supplements market in 2022. The Middle East is expected to be the largest growing region in the global vitamin and minerals market during the forecast period. The regions covered in the global vitamins and minerals supplements market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the vitamins and minerals supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The vitamins and mineral supplements market consists of sales of biotin, iron, glutamine, caffeine, and more. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global vitamin and minerals market is segmented - 1) By Type: Multivitamin, Single Vitamin, Multi Mineral, Single Mineral 2) By Application: Energy And Weight Management, General Health, Bone And Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-Cancer, Other Applications 3) By Distribution Channel: Pharmacies ANd Drug Stores, Supermarkets And Hypermarkets, Online Channels 4) By End-User: Adults, Geriatric, Pregnant Women, Children, Infants

Anticoagulants refer to a drug used to prevent and treat blood clots in the heart and blood arteries. called a blood thinner as well. It is utilised to slow down the body's clotting process. These are blood thinners, but they do not thin the blood, instead, they avoid or minimize clots or thrombi. The main drug classes of anticoagulants are Factor Xa Inhibitor, Heparin & LMWH, Vitamin K Antagonist, and others. Factor Xa inhibitors are anticoagulants that inhibit clot formation by specifically and reversibly blocking the function of clotting factor Xa. The different routes of administration include oral anticoagulants, and injectable anticoagulants and are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacy. It is used in venous thromboembolism, atrial fibrillation or flutter, coronary artery disease, and others and is used in hospitals, home care, speciality centres, and others. The anticoagulants market research report is one of a series of new reports from The Business Research Company that provides anticoagulants market statistics, including anticoagulants industry global market size, regional shares, competitors with an anticoagulants market share, detailed anticoagulants market segments, market trends and opportunities, and any further data you may need to thrive in the anticoagulants industry. This anticoagulants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global anticoagulants market size grew from $40.63 billion in 2022 to $44.81 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The anticoagulants market size is expected to grow to $66.32 billion in 2027 at a CAGR of 10.3%. The increasing cardiovascular diseases are a key factor driving the growth of the anticoagulants market over the coming years. CVDs (cardiovascular diseases) are a category of heart and blood vessel problems. Cardiovascular diseases (CVDs) are the primary, source of death worldwide with low- and middle-income nations accounting for three-quarters of CVD deaths. Anticoagulation pharmacotherapy known as direct oral anticoagulants is used to minimize thrombosis in a variety of cardiovascular situations. According to the World Health Organization report in 2021, cardiovascular diseases claimed the lives of 17.9 million individuals worldwide, accounting for 32% of all deaths. Heart attacks and strokes were responsible for 85% of these deaths. Therefore, the increasing cardiovascular diseases drive the growth of the anticoagulants market. The ongoing clinical trials of anticoagulant treatments for COVID-19 are shaping the anticoagulants market. Major companies operating in the anticoagulants sector are concentrating on establishing clinical trials of anticoagulant medications to lower the risk of COVID-19-related blood clotting in adults. For instance, in March 2021, The National Institutes of Health (NIH) in the USA started the final of three Phase III clinical trials of blood thinners (anticoagulants) to prohibit life-threatening blood clots in elderly people with COVID-19. The ACTIV-4 trials will help to resolve concerns about the use of anticoagulants also known as antithrombotics in the treatment of COVID-19. In July 2020, Alexion Pharmaceuticals Inc., a US-based biopharmaceutical company acquired Portola Pharmaceuticals Inc., for an amount of $1.41 billion. Through this acquisition Andexxa, a factor Xa inhibitor reversal agent marketed as Ondexxya in Europe has been added to Alexion Pharmaceuticals Inc.,'s commercial portfolio. Portola Pharmaceuticals Inc., is a US-based clinical-stage biopharmaceutical company with an anticoagulant Bevyxxa under its portfolio. Major players in the anticoagulants market are GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo, Alexion Pharmaceuticals Inc., Otsuka, Leo Pharma, Eisai Co. Ltd., and Amphastar Pharmaceutica. North America was the largest region in the anticoagulants market in 2022. The regions covered in the anticoagulants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the anticoagulants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The anticoagulants market consists of sales of rivaroxaban, dabigatran, apixaban, and edoxaban. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global anticoagulants market is segmented - 1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes 2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy 4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications 5) By End User: Hospitals, Homecare, Specialty Centers, Other End-Users

Multivitamin capsules and tablets refers to multivitamin drugs that are used to treat or prevent vitamin deficiencies brought on by a poor diet, specific diseases, or pregnancy. Vitamins are crucial for maintaining your health because they serve as the body's building blocks. Multivitamins tablets and capsules are a combination of many different vitamins that are normally found in foods and other natural sources The main types of products include multivitamins tablets and multivitamins capsules. A multivitamin is a pill that people take every day which contains a variety of vitamins and minerals. The different distribution channels include store-based, non-store-based and are used for energy and weight management, general health, bone, and joint health, gastrointestinal health, immunity, cardiac health, diabetes, anti-cancer, and other applications. These capsules and tablets are mainly used by adults, the geriatric population, pregnant women, children, and infants. The multivitamin capsules and tablets market research report is one of a series of new reports from The Business Research Company that provides multivitamin capsules and tablets market statistics, including multivitamin capsules and tablets industry global market size, regional shares, competitors with a multivitamin capsules and tablets market share, detailed multivitamin capsules and tablets market segments, market trends and opportunities, and any further data you may need to thrive in the multivitamin capsules and tablets industry. This multivitamin capsules and tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global multivitamin capsules and tablets market size grew from $20.28 billion in 2022 to $22.38 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The multivitamin capsules and tablets market size is expected to grow to $33.05 billion in 2027 at a CAGR of 10.2%. Increasing health consciousness among individuals is driving the market for multivitamin capsules and tablets. Multivitamins tablets or capsules are often prescribed by doctors to treat or prevent vitamin deficiency due to poor diet, certain illnesses, or during pregnancy as it contains different vitamins that are normally found in foods and other natural sources. The demand for multivitamins also increased attributing to rising health concerns associated with the COVID-19 pandemic. According to SVC Labs Ltd., a UK-based supplement manufacturer the sales for vitamins, minerals and supplements have increased since the beginning of March 2020 as people are concerned with boosting immune health. The sales of vitamins, minerals, and supplements have experienced growth of approximately 20%-140% since March 2020. Therefore, rising health consciousness is expected to drive the multivitamin capsules and tablets market during the forecast period. Shifting consumer focus towards flavored gummy vitamins for all ages is shaping the multivitamin capsules and tablets market. Consumers are searching for more convenient and entertaining supplement experiences, which will lead to a move toward flavored gummy vitamins. For instance, in April 2021, Persona Nutrition, a US-based company that provides personalized daily supplement packs launched daily gummy vitamin packs for the entire family. These daily packs are designed to help users achieve specific health goals, such as immune health, focus, relaxation, everyday support, and hair, skin, and nail health. This family pack includes multivitamins to boost muscle and nerve function. In February 2021, Nature's Way Products, a US-based wellness product manufacturing company, acquired Baze Labs for an undisclosed amount. Through this acquisition, Nature's Way increases its personalized nutrition product capabilities for its customers, home blood test services, and monthly subscription programs. Baze Labs is a US-based personalized nutrition manufacturing company specializing in the development of vitamins and supplements. Major players in the multivitamin capsules and tablets market are Herbalife Nutrition, Abbott Laboratories, Bayer, Nature's Bounty Co., Bionova Lifesciences, Ayanda GmbH, NutraMarks Inc., American Health Inc., Otsuka Holdings Co. Ltd., Nature's Way Products, Glanbia PLC., Pfizer, Mylan N.V., and Dymatize. Asia-Pacific was the largest region in the multivitamin capsules and tablets market in 2022. North America was the second-largest market in the multivitamin capsules and tablets market. The regions covered in multivitamin capsules and tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the multivitamin capsules and tablets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The multivitamin capsules and tablets market consists of sales of antioxidant capsule, iron folic acid tablet, multivitamin gummy, and nicotinamide. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global multivitamin capsules and tablets market is segmented - 1) By Type: Multivitamins Tablets, Multivitamins Capsules 2) By Distribution Channel: Store Based, Non-Store Based 3) By Application: Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-Cancer, Other Applications 4) By End User: Adults, Geriatric, Pregnant Women, Children, Infants

The food encapsulation technique is used for incorporating food ingredients, cells, enzymes, and certain other materials into small capsules as the encapsulated materials are protected from heat, moisture, or other extreme condition. Food encapsulation is used to mask taste, color, flavor, and odor, and enhance the viability and stability of the food product. The main food encapsulation technologies include micro encapsulation, nano encapsulation, hybrid technology, and macro encapsulation. Microencapsulation is the process of reducing the volatility, adverse aroma, and reactivity of food products. When exposed to heat, light, moisture, or other adverse conditions, it offers greater stability to food products. The different shell materials in food encapsulation are polysaccharides, proteins, lipids, emulsifiers, and other shell materials. The different food encapsulation core phases are minerals, organic acids, vitamins, enzymes, probiotics, additives, essential oils, prebiotics, and other substances, which are used for applications in dietary supplements, functional food products, bakery products, confectionery, beverages, dairy products, and other applications. The food encapsulation market research report is one of a series of new reports from The Business Research Company that provides food encapsulation market statistics, including food encapsulation industry global market size, regional shares, competitors with food encapsulation market share, detailed food encapsulation market segments, market trends and opportunities, and any further data you may need to thrive in the food encapsulation industry. This food encapsulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global food encapsulation market size grew from $36.64 billion in 2022 to $39.18 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The food encapsulation market size is expected to grow to $50.68 billion in 2027 at a CAGR of 6.6%. The rising demand for fortified and functional foods is expected to propel the growth of the food encapsulation market. Fortified food has added nutrients that do not occur in the food naturally. Functional food reduces the risk of disease and promotes optimal health beyond basic nutrition. Fortified and functional foods are widely used in the food encapsulation market, as they offer added nutrients or healthy ingredients. For instance, in 2020, Switzerland-based food and beverage processing company, Nestle, delivered 196.6 billion fortified servings of food and beverages through their popular brands, including Bear Brand, Cerevita, and Maggi. Technological advancement is a key trend gaining popularity in the food encapsulation market. Technological advancement is the discovery of knowledge that advances technology. For instance, in February 2022, Givaudan, a Switzerland-based manufacturer of food and flavors, launched PrimeLock+, a breakthrough fat encapsulation technology that reduces 30% of the calories and 75% of the fat content in meat substitutes. The innovation in fat encapsulation also offers increased authenticity and flavor stabilization, which allows companies to create tastier, lower-fat, plant-based products such as burgers, sausages, and meatballs while improving the eating experience. In February 2021, International Flavors & Fragrances, Inc. (IFF), a US-based producer of value-added ingredients, merged with the Nutrition and Biosciences Business of DuPont for a deal amount of $7.3 billion. Through this merger, IFF aims to create ingredients and solutions across a wide range of end-markets, including food and beverage, health and wellness, and home and personal care. DuPont Nutrition Biosciences is a Denmark-based developer and producer of food and beverage ingredients, enzymes, and bio-based solutions that also provides food encapsulation solutions. Major players in the food encapsulation market are Cargill, Incorporated, DuPont, Royal DSM, FrieslandCampina, Kerry, International Flavors & Fragrances Inc., Symrise, Balchem Inc., Firmenich SA, Advanced Bionutrition Corp, Aveka, Lycored, Encpasys LLC, Blue California, FierslandCampina, Kievit, Coating Place Inc., Vitablend, Clextral, Tastetech, and Givaudan North America was the largest region in the food encapsulation market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food encapsulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the food encapsulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The food encapsulation market consists of sales of microencapsulation, nanoencapsulation, hybrid technology, and macro encapsulation. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global food encapsulation market is segmented - 1) By Technology: Micro Encapsulation, Nano Encapsulation, Hybrid Technology, Macro Encapsulation 2) By Shell Material: Polysaccharides, Proteins, Lipids, Emulsifiers, Other Shell Materials 3) By Core Phase: Minerals, Organic Acids, Vitamins, Enzymes, Probiotics, Additives, Essential Oils, Prebiotics, Other Substances, 4) By Application: Dietary Supplements, Functional Food Products, Bakery Products, Confectionery, Beverages, Dairy Products, Other Applications

The gastrointestinal drugs market consists of sales of gastrointestinal drugs by entities (organizations, sole traders and partnerships) that produce gastrointestinal drugs to treat gastrointestinal diseases such as ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors, Sucralfate, and Misoprostol), antiemetics, adsorbents, anticholinergics, opiates, intestinal flora modifiers, emollient/surfactants, hyperosmotic, saline, and simulant/irritant. The main types of gastrointestinal drugs are antacids, antiulcerants, vitamin and minerals, antiobesity, antiemetics and antinauseants and antidiarrhoeals. Antacids are medications that counteract (neutralise) stomach acid to relieve indigestion and heartburn. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores and others. The global gastrointestinal drugs market size is expected to grow from $71.85 billion in 2021 to $75.63 billion in 2022 at a compound annual growth rate (CAGR) of 5.3%. The change in the gastrointestinal drugs market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The gastrointestinal drugs market is expected to reach $105.51 billion in 2026 at a CAGR of 8.7%. The aging population profile of most countries will contribute to the growth of the gastrointestinal drugs market. The increase in patient pool due to rising geriatric population globally, will contribute significantly to the growth of the market during the forecast period. According to the WHO, by 2030, one in every six people on the planet will be 60 or older. The proportion of the population aged 60 and up will rise from 1 billion in 2020 to 2.2 billion by 2050. This rise in the geriatric population increased the demand for medical care and drove the healthcare expenditure. This will led to increased demand for pharmaceuticals products, significantly impacting market growth during this period. During the forecast period, the growth of the gastrointestinal drugs market will be restrained by patent expiration of branded gastrointestinal drugs. In general, pharmaceutical companies invest a large sum of money in the drug development process and patents. During the patency period, the company holding the patent holds exclusivity for the manufacturing and distribution of drugs. Post expiration of patency, generic versions of the drugs are manufactured by other companies with prices much lower than the original branded drugs. Overall, this will negatively impact the growth of the market in terms of value. Major companies in the gastrointestinal drug industry are investing in making oral capsules of macromolecular drugs for gastrointestinal diseases for making the drug more effective. Macromolecular drugs, such as peptides, proteins, and antibodies, form a new class of drugs which can treat diseases of the gastrointestinal tract, such as inflammatory bowel disease. These macromolecular drugs are usually injected and only a fraction of the administered dose reaches the disease sites in the gastrointestinal tract. Thus, major companies such as Eli Lilly have been increasingly investing in making oral capsules for macromolecular drugs. The company invested $5 million to enter into a collaboration with Entrega to study the oral delivery of complex molecules, such as peptides to combat gastrointestinal diseases. Major companies in the gastrointestinal drugs market include Takeda Pharmaceuticals, Bayer AG, Abbott Laboratories, Otsuka Holdings Co ltd, Johnson & Johnson, Reckitt Benckiser Group plc, Bausch Health Companies Inc., Sanofi S.A, Procter & Gamble and Daiichi Sankyo Company. North America was the largest region in the gastrointestinal drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the gastrointestinal drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the gastrointestinal drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The global gastrointestinal drugs market is segmented - 1) By Type: Antacids, Antiulcerants, Vitamin and Minerals, Antiobesity, Antiemetics and Antinauseants, Antidiarrhoeals 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others 3) By Route of Administration: Oral, Parenteral, Others 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs